<unk> , sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder.<unk>  (other names: RVT-901; MK4618; KRP114V; URO-901) is a selective beta 3 adrenergic receptor agonist. The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection. It was approved for medical use in the United States in December 2020.
Vibegron
Seviteronel
Voretigene neparvovec
Obetrol
Gestodene
Fosfestrol
Retroprogesterone
Chloroethynylnorgestrel